menu
    • menu

    Company profile for Qualigen Therapeutics

    NEW Drugs in Dev.: 5
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Qualigen is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack® diagnostic platform. The FastPack® line of FDA-cleared and CE-Marked products has been used successfully in diagnostics since 2002. Our therapeutics pipeline includes cancer drug compounds such as AS1411, AS1411...
    Qualigen is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack® diagnostic platform. The FastPack® line of FDA-cleared and CE-Marked products has been used successfully in diagnostics since 2002. Our therapeutics pipeline includes cancer drug compounds such as AS1411, AS1411-GNP and RAS-F, as well as STARS, a DNA/RNA-based treatment device. By combining our demonstrated ability to quickly develop and commercialize innovative medical products with the advanced capabilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Qualigen TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2042 Corte del Nogal Suite B Carlsbad, CA 92011
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.qualigeninc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/qualigen-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Qualigen Therapeutics Stockholders Approve Rebrand To Aixcrypto
    Qualigen Therapeutics Stockholders Approve Rebrand To Aixcrypto

    16 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/16/3188761/0/en/Qualigen-Therapeutics-Stockholders-Approve-All-Proposals-with-Majority-Vote-Company-to-Rebrand-as-AIxCrypto-Holdings-Inc-Nasdaq-AIXC-Following-November-20-Nasdaq-Ceremony-and-Annou.html

    GLOBENEWSWIRE
    16 Nov 2025
    Share Share
    Qualigen Pharma Teams Up With BitGo For Initial Multi-Asset C10
    Qualigen Pharma Teams Up With BitGo For Initial Multi-Asset C10

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172439/0/en/Qualigen-Therapeutics-Partners-with-BitGo-to-Execute-First-Multi-Asset-C10-Treasury-Allocation.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Qualigen Therapeutics Launches C10 Cryptocurrency Asset
    Qualigen Therapeutics Launches C10 Cryptocurrency Asset

    12 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165259/0/en/Qualigen-Therapeutics-Announces-the-Official-Launch-of-C10-Cryptocurrency-Asset-Treasury-DAT-Purchases-Why-Is-This-Pullback-the-Golden-Moment-CXC10-Has-Been-Waiting-For.html

    GLOBENEWSWIRE
    12 Oct 2025
    Share Share
    Qualigen Therapeutics Reveals Executive And Board Appointments
    Qualigen Therapeutics Reveals Executive And Board Appointments

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3162180/0/en/Qualigen-Therapeutics-NASDAQ-QLGN-Announces-Executives-Board-of-Directors-Appointments-and-Auditor-Transition.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Qualigen Closes $41M PIPE, Shifts Focus to Crypto Business
    Qualigen Closes $41M PIPE, Shifts Focus to Crypto Business

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158446/0/en/Qualigen-Therapeutics-Announces-Successful-Closing-of-41-Million-PIPE-Financing-Led-by-Faraday-Future-Accelerating-New-Business-Transformation-into-Crypto.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Faraday Future Invests $41M in Qualigen Pharma for Crypto Push
    Faraday Future Invests $41M in Qualigen Pharma for Crypto Push

    19 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/19/3153465/0/en/Faraday-Future-Announces-Strategic-41-Million-Investment-in-Qualigen-Therapeutics-Inc-NASDAQ-QLGN-f-for-Crypto-Business-Through-PIPE-Transaction.html

    GLOBENEWSWIRE
    19 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search